These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two support the concept of focusing on ACKR3 as a singular approach to modulate the opioid method, which could open up new therapeutic avenues for opioid-connected Conditions.We independently research,